BIOTON S.A

BIOTON Spólka Akcyjna, a biotechnological company, manufactures, sells, and markets medicines, pharmaceutical preparations, and pharmaceutical substances. The company offers recombinant human insulin in pharmaceutical substance form and as preparations for injections; and oral hypoglycemic drugs, including glimepiride and metformin. It also provides FOOT CREAM prodiab that is used for the treatment of dry and atopic skin; HEALTHY EYES prodiab, a dietary supplement for the proper functioning of the eye; Healthy Heart prodiab, a dietary supplement for the proper functioning of the heart and the cardiovascular system; and HEALTHY HEART PLUS prodiab and VITAMINS AND MINERALS prodiab, which are used as dietary supplement for the cardiovascular system. In addition, the company engages in advertising, consulting, and licensing operations. Further, it provides an OTC products line focusing on diet supplements, nutritional uses, and cosmetics. The company has operations in Poland, Russia, Italy, India, Australia, Singapore, Switzerland, China, Thailand, the United Arab Emirates, South Korea, and Cyprus. BIOTON Spólka Akcyjna has strategic partnership with LG Life Science and Rentschler Biotechnologie. The company is based in Ozarów Mazowiecki, Poland.